Connect with us

Trending

Study Finds mRNA Vaccines Have Caused Irreversible Heart Damage to Billions of People

Published

on

The mRNA vaccines have caused irreversible heart defects to billions of people around the world, according to a bombshell new study out of Switzerland.

A single dose of Moderna’s experimental Covid jab caused high levels of troponin, a protein the heart releases when it is injured, in a large number of recipients who participated in the Swiss study.

“Subclinical mRNA vaccine-associated myocardial injury is much more common than estimated based on passive surveillance,” the researchers concluded.

The paper was published last week in the peer-reviewed European Journal of Heart Failure.

Billions of people around the world have received mRNA jabs. The study suggests a large percentage of these people will suffer longterm heart damage as a result.

Unreported Truths reports: The researchers conducted the tests on 777 employees at University Hospital Basel, one of Switzerland’s top medical centers, from December 2021 through February 2022.

The employees had already been scheduled to receive mRNA boosters and were asked if they would undergo a blood test for troponin levels three days later.

In other words, the researchers conducted “active surveillance” on them to trace potential side effects, as opposed to “passive surveillance” vaccine safety systems like the federal government’s VAERS, which depend on patients or doctors to report problems.

The Moderna vaccinees were a healthy group, with an average age of 37 and few preexisting heart problems. About 70 percent were women.

But post-jab blood tests found that 40 of the jab recipients had highly elevated troponin levels, above the 99th percentile for average women or men. About five times as many people had extremely high troponin as should have in a random sample.

After the scientists removed anyone with a plausible non-jab explanation, 22 people – or 1 in 35 of those they tested – remained injured by the Moderna jab.

(Swiss researchers doing the studies American scientists won’t)

(SOURCE)

The study contained another striking finding.

The researchers reported that 20 of the injured recipients were women, while only two were men. Even adjusting for the fact that more women were tested, women were almost five times as likely to have elevated troponin.

Many large studies have shown that young men are at the highest risk from mRNA-caused myocarditis and pericarditis, or acute heart inflammation, following the jabs. But this study suggests women may be suffering more subtle damage.

Unlike organs such as the liver, the heart cannot regenerate dead muscle tissue. So even a minor cardiac injury can raise the risk for problems years later. In 2016, a long-term study found that people whose troponin levels rose over time had a much higher risk of heart failure and death.

The researchers referred to the damage as “transient.”

That view was somewhat optimistic. The scientists conducted only one follow-up troponin test on the injured people, a day after the first test. The second test showed that many of them, especially those with the highest troponin levels in the first test, had only small declines in their troponin levels.

Without further tests, no one can be sure the declines continued, or how quickly – if ever – troponin levels returned to normal.

(Transient? Maybe.)

In their discussion, the researchers noted that this is the third – and largest – study using blood tests shortly after vaccination to examine post-mRNA heart injury. (The two previous studies took place in Israel and Thailand.) All three papers have shown far higher rates of damage than “passive surveillance” vaccine safety systems.

“Additional active surveillance studies are needed,” they wrote.

But if the last three years are any guide, those studies will not be run in the United States.

Nearly every important finding on mRNA safety has come from researchers based outside the United States – even though Moderna and Pfizer are American companies and the United States administered far more mRNA shots than anywhere else.

Biden Administration

The Biden Admin’s Attempt to Ban Cigarettes Just Days Before Trump Returns Setting Up For Boost in Criminal Cartels and Black Market

Published

on


Biden Administration’s Nicotine Ban: A Move Toward Regulation or a Boost for Cartels?

In a controversial move during its final days, the Biden administration is advancing a proposal to drastically lower nicotine levels in cigarettes, effectively banning traditional products on the market. While the administration frames the measure as a step toward reducing smoking addiction, critics argue it will backfire, fueling black markets and empowering criminal cartels.

Regulatory Shift with Broad Implications

The Food and Drug Administration (FDA) confirmed that its proposed rule to establish maximum nicotine levels in cigarettes has completed regulatory review. The measure is part of a broader effort to make cigarettes less addictive, potentially shaping one of the most impactful tobacco policies in U.S. history.

FDA Commissioner Robert Califf previously stated that the initiative aims to “decrease the likelihood that future generations of young people become addicted to cigarettes and help more currently addicted smokers to quit.” However, opponents warn that this policy could create new public safety and economic challenges.

A “Gift” to Organized Crime

Critics of the proposed regulation, including former ATF official Rich Marianos, are sounding the alarm. Marianos described the plan as a “gift with a bow and balloons to organized crime cartels,” arguing that it would open the floodgates for illegal tobacco trafficking.

Mexican cartels, Chinese counterfeiters, and Russian mafias are well-positioned to exploit the demand for high-nicotine cigarettes. These groups, already entrenched in smuggling operations, would likely ramp up efforts to meet consumer demand. This shift would not only enrich organized crime but also compromise public health by introducing unregulated, potentially more harmful products into the market.

Unintended Consequences for Public Health

While the FDA’s goal is to reduce smoking rates, experts suggest the policy may have the opposite effect. Smokers could resort to “compensatory smoking,” consuming more cigarettes to achieve their desired nicotine levels. This behavior increases exposure to harmful chemicals like tar, negating the intended health benefits.

Additionally, the regulation could discourage smokers from transitioning to safer alternatives, such as vaping or nicotine replacement therapies. By removing higher-nicotine products from the legal market, the government risks alienating individuals who might otherwise seek healthier pathways to quitting smoking.

National Security and Economic Concerns

Beyond health implications, the nicotine ban raises significant national security issues. A 2015 State Department report highlighted the role of tobacco trafficking in funding terrorist organizations and criminal networks. Reducing nicotine levels in cigarettes could expand this illicit market, providing criminal groups with a lucrative new revenue stream.

Moreover, law enforcement agencies could face increased pressure as they work to combat tobacco smuggling alongside ongoing efforts to address opioid and fentanyl trafficking. This strain on resources could compromise broader public safety initiatives.

Balancing Public Health and Freedom

The proposed nicotine reduction also ignites debates over personal freedom. While reducing addiction is a laudable goal, critics argue that adults should retain the right to make their own choices regarding tobacco use. For many, the measure feels like government overreach, imposing a paternalistic approach to health regulation.

As the Biden administration pushes forward with its nicotine reduction proposal, the policy’s broader implications remain uncertain. While intended to curb addiction and promote public health, critics warn of significant risks, including empowering organized crime, increasing smoking rates, and straining law enforcement resources.

A more balanced approach—focused on education, harm reduction, and access to cessation resources—may better address smoking-related challenges without creating new societal harms.


Continue Reading

Trending

McDonald’s to Scrap DEI Practices

Published

on

McDonald’s has announced plans to scale back certain diversity, equity, and inclusion (DEI) initiatives, citing a “shifting legal landscape” following the U.S. Supreme Court’s 2023 decision to end affirmative action in college admissions.

The fast-food corporation intends to retire specific diversity goals for senior leadership positions and discontinue a program that encouraged suppliers to implement diversity training and enhance minority representation within their leadership teams. Additionally, McDonald’s will pause participation in external surveys that assess workplace inclusion, a move similar to recent actions by companies like Lowe’s and Ford Motor Co.

Despite these changes, McDonald’s emphasizes its ongoing commitment to fostering an inclusive environment. The company reports that 30% of its U.S. leaders come from underrepresented groups and that it has achieved gender pay equity across all levels since setting that goal in 2021. McDonald’s also plans to continue supporting efforts to maintain a diverse base of employees, suppliers, and franchisees, and will keep reporting its demographic information.

This development aligns with a broader trend among major corporations reassessing their DEI strategies in response to legal and societal shifts. Companies such as Walmart, John Deere, and Harley-Davidson have similarly rolled back diversity programs following the Supreme Court’s ruling and subsequent conservative backlash.

Continue Reading

Trending

Tesla Accused of Replacing Thousands of Laid-off U.S. Workers With Foreign Employees on H-1B Visas

Published

on

Reports have surfaced alleging that Tesla replaced thousands of laid-off U.S. workers with foreign employees on H-1B visas, prompting scrutiny of the company’s hiring practices and raising questions about broader labor policies. This controversy gained traction following Tesla’s April 2024 layoffs of approximately 15,000 employees, particularly in Texas and California, and the company’s subsequent requests for over 2,000 H-1B visas—more than three percent of the total available nationwide.

The H-1B visa program allows U.S. companies to hire foreign workers for specialized roles when there is a shortage of qualified domestic candidates. However, critics argue that the program is sometimes exploited to replace higher-paid American workers with lower-cost foreign labor. In Tesla’s case, some former employees have claimed that senior engineers were replaced by younger, less experienced foreign engineers at significantly lower salaries.

This has sparked concerns about potential misuse of the H-1B program, with critics alleging that companies like Tesla may be prioritizing cost-cutting measures over the retention of skilled U.S. workers.

Tesla CEO Elon Musk, who is an immigrant and has benefitted from U.S. visa programs, has been an outspoken defender of the H-1B program. In a recent post on his social media platform, X, Musk sharply responded to critics calling for reforms to the program. He emphasized the importance of H-1B visas in attracting talented individuals who have contributed to the growth of companies like SpaceX and Tesla, which he argued have played a significant role in strengthening the U.S. economy. Musk’s comment, quoting a line from the film Tropic Thunder

, sparked a wide range of reactions, further polarizing opinions on the issue.

Supporters of the H-1B program, including Musk and entrepreneur Vivek Ramaswamy, argue that the U.S. faces a shortage of skilled workers, especially in STEM fields, and that foreign talent is essential for innovation and economic progress. They contend that the H-1B program helps fill these gaps and sustains U.S. competitiveness on the global stage.

On the other hand, critics, particularly from conservative groups, argue that the program is often misused to displace American workers and should be reformed to ensure it is used for its intended purpose—addressing real talent shortages rather than cutting labor costs.

The Tesla situation adds to the broader debate over immigration and labor policies in the U.S. As the discourse continues to intensify, Tesla’s use of the H-1B program may serve as a focal point in discussions about labor policy and its impact on American workers, particularly in the technology sector.

SOURCE: ELECTREK

Continue Reading

Trending